Try our beta test site

Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Comprehensive Cancer Network
Information provided by (Responsible Party):
Manisha Shah, Ohio State University Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT01723202
First received: October 22, 2012
Last updated: January 26, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 31, 2019
  Estimated Primary Completion Date: December 31, 2017 (Final data collection date for primary outcome measure)